Default CI fitting
DeviceProgramming of cochlear implant speech processor according to standard clinical care
NCT Number: NCT05451628
Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
University Hospital Brussels, Brussels, Brussels Capital, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Programming of cochlear implant speech processor according to standard clinical care
Programming of cochlear implant speech processor with anatomy-based fitting
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 3 months post-activation
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
Time frame: 6 months post-activation
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 1 day visit (At the activation of the sound processor)
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 2 weeks post-activation
Time frame: 1 months post-activation
Time frame: 3 months post-activation
Time frame: 6 months post-activation
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Time frame: 12 months post-activation
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
Time frame: 24 months post-activation
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Time frame: 12 months post-activation
Time frame: 24 months post-activation
Universitair Ziekenhuis Brussel
Other
Acronym: ABFmulti
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05558514
Cochlear Implants, Ear Diseases
London, Ontario, Canada
View Trial DetailsNCT06453343
Cochlear Implants, Ear Diseases
Nijmegen, Netherlands
View Trial DetailsNCT05973669
Cochlear Implant, Cochlear Implant Recipients
Iowa City, Iowa, United States
View Trial DetailsNCT06734039
Asymmetric Hearing Loss, Cochlear Implants
Iowa City, Iowa, United States
View Trial Details